Persistent antigen is essential for sustaining Leishmania major –specific memory CD4 + T cells and long-term immunity
Science Advances · 06.03.2026 · 12 (10)
DOI: 10.1126/sciadv.aeb3345 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 06.03.2026. Verfasst von Zhirong Mou und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Max Rady College of Medicine, University of Manitoba, Winnipeg, Canada. Hauptthemen laut MEDLINE: Leishmania major, CD4-Positive T-Lymphocytes, Immunologic Memory, Leishmaniasis, Cutaneous. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Research Manitoba, Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada.
Abstract (Originalsprache)
Memory CD4 + T cells are central to long-term immunity, yet their persistence in the absence of antigen remains controversial. Lifelong immunity following cutaneous leishmaniasis is primarily mediated by CD4 + T cells, but whether persistent parasites are required for sustaining this immunity has not been empirically established. Using a nonpersistent Leishmania major strain ( dhfr-ts –deficient), we demonstrate that loss of antigen leads to a decline in Leishmania -specific CD4 + T cells and susceptibility to reinfection. To elucidate the mechanism, we developed Leishmania phosphoenolpyruvate carboxykinase (PEPCK)-specific CD4 + T cell receptor transgenic (PEG) mice, enabling precise tracking of Leishmania -specific memory CD4 + T cells. Both in vitro and in vivo–generated memory PEG cells progressively declined in the absence of antigen, independent of major histocompatibility complex II expression. Mice infected with PEPCK antigen–deficient L. major failed to sustain recall responses and secondary immunity. These findings in a L. major model system argue that persistent antigen may be indispensable for maintaining memory CD4 + T cells and ensuring durable immunity against chronic infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Immunology, Max Rady College of Medicine, University of Manitoba, Winnipeg, Canada.
- Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, USA.
- Department of Immunology, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Japan.
- Department of Computer Science, Faculty of Science, University of Manitoba, Winnipeg, Canada.
- Department of Internal Medicine, Max Rady College of Medicine, University of Manitoba, Winnipeg, Canada.
- Department of Medical Microbiology, Max Rady College of Medicine, University of Manitoba, Winnipeg, Canada.
ORCID-Profile: Zhirong Mou, Roma Zayats, Enitan Salako, Somtochukwu S Onwah, Dong Liu, Hiroshi Hamana, Hiroyuki Kishi, Da Tan, Carson Leung, Janilyn Arsenio, Thomas T Murooka, Jude E Uzonna
Förderung
- Research Manitoba
- Canadian Institutes of Health Research
- Natural Sciences and Engineering Research Council of Canada
Zitieren
APA
Mou, Z., Zayats, R., Salako, E., Ikeogu, N., Onwah, S. S., Liu, D., Hamana, H., Kishi, H., Tan, D., Leung, C., Arsenio, J., Murooka, T. T., & Uzonna, J. E. (2026). Persistent antigen is essential for sustaining Leishmania major –specific memory CD4 + T cells and long-term immunity. Science Advances, 12(10). https://doi.org/10.1126/sciadv.aeb3345
Vancouver
Mou Z, Zayats R, Salako E, Ikeogu N, Onwah SS, Liu D, et al. Persistent antigen is essential for sustaining Leishmania major –specific memory CD4 + T cells and long-term immunity. Science Advances. 2026;12(10). doi:10.1126/sciadv.aeb3345
BibTeX
@article{Mou2026,
author = {Mou, Zhirong and Zayats, Roma and Salako, Enitan and Ikeogu, Nnamdi and Onwah, Somtochukwu S and Liu, Dong and Hamana, Hiroshi and Kishi, Hiroyuki and Tan, Da and Leung, Carson and Arsenio, Janilyn and Murooka, Thomas T and Uzonna, Jude E},
title = {Persistent antigen is essential for sustaining Leishmania major –specific memory CD4 + T cells and long-term immunity},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {10},
doi = {10.1126/sciadv.aeb3345}
}
EUVIMED